Rx · PZN 14275309, 15193335, 14275290, 16687832…
XELJANZ 11 mg prolonged-release tablets
German trade nameXELJANZ 11 mg Retardtabletten
Consistently available
9.6out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
XELJANZ 11 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsXELJANZ 11 mg prolonged-release tablets contains the active ingredient Tofacitinib and comes as Prolonged-release tablets. 11 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available. 9 of the 11 packs are currently marketed according to our records.
Pack sizes · 11 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 14275290 | 9.4 | 9.6 | ~ €2,339 |
| 14275309 | 4.3 | 5.0 | ~ €720 |
| 16687849 | 2.7 | 2.9 | ~ €2,339 |
| 16941992 | 1.3 | 1.7 | ~ €2,339 |
| 15193335 | 0.0 | 0.0 | N/A |
| 16687832 | 0.0 | 0.0 | ~ €716 |
| 17252496 | 0.0 | 0.0 | ~ €720 |
| 19871571 | 0.0 | 0.0 | ~ €716 |
| 18046244 | 0.0 | 0.0 | ~ €2,339 |
| 16941986 | 0.0 | 0.0 | ~ €720 |
| 19640127 | 0.0 | 0.0 | ~ €2,339 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch